Cargando…

Immune repertoire and evolutionary trajectory analysis in the development of diabetic nephropathy

Diabetic nephropathy (DN) is the leading cause of death and the greatest risk to the lives of people with advanced diabetes. Yet, the molecular mechanisms underlying its development and progression remain unknown. In this research, we studied the primary pathways driving DN using transcriptome seque...

Descripción completa

Detalles Bibliográficos
Autores principales: Ye, Zheng, Zhang, Yidi, Huang, Nan, Chen, Shen, Wu, Xiaodong, Li, Ling
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9537376/
https://www.ncbi.nlm.nih.gov/pubmed/36211355
http://dx.doi.org/10.3389/fimmu.2022.1006137
_version_ 1784803187091308544
author Ye, Zheng
Zhang, Yidi
Huang, Nan
Chen, Shen
Wu, Xiaodong
Li, Ling
author_facet Ye, Zheng
Zhang, Yidi
Huang, Nan
Chen, Shen
Wu, Xiaodong
Li, Ling
author_sort Ye, Zheng
collection PubMed
description Diabetic nephropathy (DN) is the leading cause of death and the greatest risk to the lives of people with advanced diabetes. Yet, the molecular mechanisms underlying its development and progression remain unknown. In this research, we studied the primary pathways driving DN using transcriptome sequencing and immune repertoire analysis. Firstly, we found that the diversity and abundance of the immune repertoire in late DN were significantly increased, while there was no significant change in early DN. Furthermore, B cell-mediated antibody responses may be the leading cause of DN progression. By analyzing master regulators, we found the key DN-driving transcription factors. In the late stage of DN, immune cells, fibroblasts, and epithelial cells were abundant, but other stromal cells were few. Early DN kidneys had a higher tissue stemness score than normal and advanced DN kidneys. We showed that DN progression involves proximal tubular metabolic reprogramming and stemness restoration using Monocle3. Through WGCNA, we found that co-expression modules that regulate DN progression and immune repertoire diversity mainly regulate immune-related signaling pathways. In addition, we also found that early DN had apparent activation of immune-related signaling pathways mainly enriched in immune cells. Finally, we found that activation of fibroblasts is typical of early DN. These results provide a research basis for further exploring the molecular biology and cellular mechanisms of the occurrence and development of DN and provide a theoretical basis for the prevention and treatment of DN.
format Online
Article
Text
id pubmed-9537376
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-95373762022-10-08 Immune repertoire and evolutionary trajectory analysis in the development of diabetic nephropathy Ye, Zheng Zhang, Yidi Huang, Nan Chen, Shen Wu, Xiaodong Li, Ling Front Immunol Immunology Diabetic nephropathy (DN) is the leading cause of death and the greatest risk to the lives of people with advanced diabetes. Yet, the molecular mechanisms underlying its development and progression remain unknown. In this research, we studied the primary pathways driving DN using transcriptome sequencing and immune repertoire analysis. Firstly, we found that the diversity and abundance of the immune repertoire in late DN were significantly increased, while there was no significant change in early DN. Furthermore, B cell-mediated antibody responses may be the leading cause of DN progression. By analyzing master regulators, we found the key DN-driving transcription factors. In the late stage of DN, immune cells, fibroblasts, and epithelial cells were abundant, but other stromal cells were few. Early DN kidneys had a higher tissue stemness score than normal and advanced DN kidneys. We showed that DN progression involves proximal tubular metabolic reprogramming and stemness restoration using Monocle3. Through WGCNA, we found that co-expression modules that regulate DN progression and immune repertoire diversity mainly regulate immune-related signaling pathways. In addition, we also found that early DN had apparent activation of immune-related signaling pathways mainly enriched in immune cells. Finally, we found that activation of fibroblasts is typical of early DN. These results provide a research basis for further exploring the molecular biology and cellular mechanisms of the occurrence and development of DN and provide a theoretical basis for the prevention and treatment of DN. Frontiers Media S.A. 2022-09-23 /pmc/articles/PMC9537376/ /pubmed/36211355 http://dx.doi.org/10.3389/fimmu.2022.1006137 Text en Copyright © 2022 Ye, Zhang, Huang, Chen, Wu and Li https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Immunology
Ye, Zheng
Zhang, Yidi
Huang, Nan
Chen, Shen
Wu, Xiaodong
Li, Ling
Immune repertoire and evolutionary trajectory analysis in the development of diabetic nephropathy
title Immune repertoire and evolutionary trajectory analysis in the development of diabetic nephropathy
title_full Immune repertoire and evolutionary trajectory analysis in the development of diabetic nephropathy
title_fullStr Immune repertoire and evolutionary trajectory analysis in the development of diabetic nephropathy
title_full_unstemmed Immune repertoire and evolutionary trajectory analysis in the development of diabetic nephropathy
title_short Immune repertoire and evolutionary trajectory analysis in the development of diabetic nephropathy
title_sort immune repertoire and evolutionary trajectory analysis in the development of diabetic nephropathy
topic Immunology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9537376/
https://www.ncbi.nlm.nih.gov/pubmed/36211355
http://dx.doi.org/10.3389/fimmu.2022.1006137
work_keys_str_mv AT yezheng immunerepertoireandevolutionarytrajectoryanalysisinthedevelopmentofdiabeticnephropathy
AT zhangyidi immunerepertoireandevolutionarytrajectoryanalysisinthedevelopmentofdiabeticnephropathy
AT huangnan immunerepertoireandevolutionarytrajectoryanalysisinthedevelopmentofdiabeticnephropathy
AT chenshen immunerepertoireandevolutionarytrajectoryanalysisinthedevelopmentofdiabeticnephropathy
AT wuxiaodong immunerepertoireandevolutionarytrajectoryanalysisinthedevelopmentofdiabeticnephropathy
AT liling immunerepertoireandevolutionarytrajectoryanalysisinthedevelopmentofdiabeticnephropathy